KBIO : Summary for KALOBIOS PHARMACEU COM USD0.001 - Yahoo Finance

U.S. Markets close in 5 hrs 24 mins

KaloBios Pharmaceuticals, Inc. (KBIO)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.45-0.03 (-1.09%)
As of 10:00AM EDT. Market open.
People also watch
CANFPBMDMCURSPHSAEZS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.48
Open2.50
Bid0.00 x
Ask0.00 x
Day's Range2.45 - 2.50
52 Week Range2.17 - 5.21
Volume1,000
Avg. Volume17,823
Market Cap36.69M
Beta4.02
PE Ratio (TTM)-0.88
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Forbes13 days ago

    Rare Diseases Patients Need More Than Miracles And Trumpcare

    Rare Disease Week was rapidly followed by more proposals to gut the ACA healthcare and the FDA, immigration and travel bans which will decimate research and healthcare (as well as being needless and cruel), and reduce research budgets. How does this help patients?

  • GlobeNewswire15 days ago

    KaloBios to Present at 29th Annual ROTH Conference

    BRISBANE, Calif., March 09, 2017-- KaloBios Pharmaceuticals, Inc., a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, announced that Cameron Durrant, ...

  • Accesswirelast month

    KaloBios to Present at Disruptive Growth & Healthcare Conference

    BRISBANE, CA / ACCESSWIRE / February 13, 2017 / KaloBios Pharmaceuticals, Inc. (OTC PINK: KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, ...